参考文献/References:
[1] Singer M,Deutschman CS,Seymour CW,et al.The third international consensus definitions for sepsis and septic shock(sepsis-3)[J].JAMA,2016,315(8):801-810.
[2] 钱幸尔,郑 旻,戴晓薇.脓毒症患者并发医院感染和死亡的危险因素分析[J].中华全科医学,2018,16(2):232-235.
[3] Li HX,Chen Y,Huo FF,et al.Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients[J].BMC Gastroenterol,2017,17(1):45-50.
[4] Blaser AR,Malbrain ML,Starkopf J,et al.Gastrointestinal function in intensive care patients:terminology,definitions and management.Recommendations of the ESICM working group on abdominal problems[J].Intensive Care Med,2012,38(4):384-394.
[5] Liu D,Yu Z,Yin J,et al.Effect of ulinastatin combined with thymosin alpha1 on sepsis:a systematic review and meta-analysis of Chinese and Indian patients[J].J Crit Care,2017,39:285-287.
[6] Chiumello D,Brochard L,Marini JJ,et al.Respiratory support in patients with acute respiratory distress syndrome:an expert opinion[J].Critical Care,2017,21(1):240-244.
[7] Li H,Zhang D,Wang Y,et al.Association between acute gastrointestinal injury grading system and disease severity and prognosis in critically ill patients:a multicenter,prospective,observational study in China[J].J Crit Care,2016,36(9):24-28.
[8] 田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510-512.
[9] Li HX,Chen Y,Huo FF,et al.Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients[J].BMC Gastroenterol,2017,17(1):45.
[10] 马建齐,郑 振,蒋 雷,等.参芪扶正注射液对脓毒症患者外周血淋巴细胞亚群及预后的影响研究[J].陕西中医,2018,39(3):365-367.
[11] 魏 宜,陈 蕊,胡英芳,等.脓毒症患者早期急性胃肠功能损伤2种分级标准评估的临床研究[J].汕头大学医学院学报,2019,32(1):31-33,40.
[12] 董科奇,邓 杰.急性胃肠损伤分级对严重脓毒症预后评估的价值[J].全科医学临床与教育,2015,13(1):15-18.
[13] 呼邦传,孙仁华,吴爱萍,等.急性胃肠损伤分级系统对重症患者适应性及临床预后的评估[J].中华医学杂志,2017,97(5):325-331.
[14] 王玲玲,陈 蕊,莫泽珣,等.老年脓毒症患者急性胃肠损伤与疾病严重程度和预后的关系[J].中国急救医学,2017,37(5):397-400.
[15] 张 玮,褚永果,李 伟,等.肠型脂肪酸结合蛋白和D-乳酸在危重症肠黏膜屏障功能的临床研究[J].临床急诊杂志,2018,19(1):6-12.
相似文献/References:
[1]李文军,于代华,宗 雷,等.脾多肽注射液对脓毒症患者血清炎症因子及免疫功能的影响*[J].陕西医学杂志,2019,(4):463.
LI Wenjun,YU Daihua,ZONG Lei,et al.Effect of spleen peptide injection on serum inflammatory factors and immune function in patients With Sepsis[J].,2019,(12):463.
[2]商跃云,张 慧,林书祥,等.脓毒症患儿外周血CD4+T细胞Bip、ATF6及DDIT3表达水平变化[J].陕西医学杂志,2019,(6):706.
SHSNG Yueyun,ZHANG Hui,LIN Shuxiang,et al.Changes of immunoglobulin binding protein, activating transcription factor 6 and DNA-damage-inducible transcript 3 protein levels in CD4+T cells in children with sepsis[J].,2019,(12):706.
[3]田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510.
TIAN Yongchao..Progress in prevention and treatment of intestinal mucosal barrier dysfunction in sepsis[J].,2020,49(12):510.
[4]王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
WANG Ting,WEI Xiaowan,YANG Liang,et al.Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value[J].,2020,49(12):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
[5]张 瑜,王 娟.脓毒症并发急性呼吸窘迫综合征患者血清血管内皮钙黏蛋白、血管生成素2表达及与预后相关性研究[J].陕西医学杂志,2022,51(2):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
ZHANG Yu,WANG Juan.Expression of serum vascular endothelial cadherin and angiopoietin 2 in sepsis patients complicated with acute respiratory distress syndrome and their correlation with prognosis[J].,2022,51(12):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
[6]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(12):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
[7]梁 红,霍红艳.右美托咪定对盲肠结扎穿孔术诱导的脓毒症大鼠急性肺损伤保护作用及其与磷酸化JAK激酶2/酪氨酸磷酸化通路的关系[J].陕西医学杂志,2023,52(1):12.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.003]
LIANG Hong,HUO Hongyan.Protective effect of dexmedetomidine on CLP-induced acute lung injury in rats with sepsis and its relationship with JAK2/STAT3 pathway[J].,2023,52(12):12.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.003]
[8]廖崇皓,徐岸楠,李世瑶,等.血清壳多糖酶3样蛋白1和几丁质酶1在脓毒症新生儿中的表达变化及其临床价值研究[J].陕西医学杂志,2024,(3):368.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.017]
LIAO Chonghao,XU Annan,LI Shiyao,et al.Expression changes of serum chitosinase 3-like protein 1 and chitinase 1 in neonatal sepsis and their clinical value[J].,2024,(12):368.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.017]
[9]吴泽华,李跃东,戴莹莹,等.降钙素原、C反应蛋白、白细胞计数和中性粒细胞比率在重症医学科脓毒症治疗预后判断中的临床价值[J].陕西医学杂志,2024,(4):540.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.023]
[10]苏一星,袁 华,周守志,等.血清微小核糖核酸-133a、微小核糖核酸-126、髓系细胞表达触发受体-1、肺表面活性蛋白A表达水平与脓毒症并发急性呼吸窘迫综合征风险及预后关系[J].陕西医学杂志,2024,(7):978.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.025]
SU Yixing,YUAN Hua,ZHOU Shouzhi,et al.Relationship between the expression levels of serum miR-133a,miR-126,TREM-1 and SP-A and the risk and prognosis of ARDS complicated with sepsis[J].,2024,(12):978.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.025]